博迈医疗创业板IPO进入问询阶段

Core Viewpoint - Guangdong Boma Medical Technology Co., Ltd. has entered the inquiry stage for its IPO on the ChiNext board, focusing on high-performance vascular interventional medical devices [1] Company Overview - Boma Medical specializes in the research, production, and global sales of complex vascular disease interventional treatment solutions, positioning itself as a leading provider in the industry [1] - The company is also recognized as a top manufacturer in the domestic vascular interventional balloon catheter sector, both in terms of production and sales volume [1] IPO Details - The company aims to raise 1.7 billion yuan through its IPO, which will be allocated to five projects, including the establishment of a global headquarters in Songshan Lake, technological upgrades at its Hunan production base (Phase I), and research and development of interventional medical devices [1]